<DOC>
	<DOCNO>NCT00234481</DOCNO>
	<brief_summary>The purpose study assess safety tolerability different dos XL844 give orally adults recurrent refractory chronic lymphocytic leukemia small lymphocytic lymphoma .</brief_summary>
	<brief_title>Safety Study XL844 Subjects With Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Patients recurrent refractory chronic lymphocytic leukemia ( CLL ) small lymphocytic lymphoma ( SLL ) Prior treatment least 2 systemic chemotherapy regimens CLL Life expectancy &gt; 3 month Adequate liver kidney function Absolute neutrophil count ≥500/mm3 ; platelet ≥50,000/dL ; hemoglobin ≥9 g/dL Willing use accept method contraception course study Negative pregnancy test ( female ) Written informed consent Chemotherapy radiotherapy within 46 week start treatment ( depend therapy ) Investigational drug within 30 day start treatment Uncontrolled intercurrent illness infection cardiovascular disease Pregnant breastfeed woman Subjects know HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>